BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 20164123)

  • 1. Suppression of mTOR via Akt-dependent and -independent mechanisms in selenium-treated colon cancer cells: involvement of AMPKalpha1.
    Lee YK; Park SY; Kim YM; Kim DC; Lee WS; Surh YJ; Park OJ
    Carcinogenesis; 2010 Jun; 31(6):1092-9. PubMed ID: 20164123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-Arylthiazolidine-4-carboxylic acid amides (ATCAA) target dual pathways in cancer cells: 5'-AMP-activated protein kinase (AMPK)/mTOR and PI3K/Akt/mTOR pathways.
    Li CM; Narayanan R; Lu Y; Hurh E; Coss CC; Barrett CM; Miller DD; Dalton JT
    Int J Oncol; 2010 Oct; 37(4):1023-30. PubMed ID: 20811725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selenium regulates cyclooxygenase-2 and extracellular signal-regulated kinase signaling pathways by activating AMP-activated protein kinase in colon cancer cells.
    Hwang JT; Kim YM; Surh YJ; Baik HW; Lee SK; Ha J; Park OJ
    Cancer Res; 2006 Oct; 66(20):10057-63. PubMed ID: 17047069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel pathway in Bcr-Abl signal transduction involves Akt-independent, PLC-gamma1-driven activation of mTOR/p70S6-kinase pathway.
    Markova B; Albers C; Breitenbuecher F; Melo JV; Brümmendorf TH; Heidel F; Lipka D; Duyster J; Huber C; Fischer T
    Oncogene; 2010 Feb; 29(5):739-51. PubMed ID: 19881535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implication of AMP-activated protein kinase and Akt-regulated survivin in lung cancer chemopreventive activities of deguelin.
    Jin Q; Feng L; Behrens C; Bekele BN; Wistuba II; Hong WK; Lee HY
    Cancer Res; 2007 Dec; 67(24):11630-9. PubMed ID: 18089792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The PI3K/Akt and mTOR/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf/ERK.
    Babchia N; Calipel A; Mouriaux F; Faussat AM; Mascarelli F
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):421-9. PubMed ID: 19661225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgens induce prostate cancer cell proliferation through mammalian target of rapamycin activation and post-transcriptional increases in cyclin D proteins.
    Xu Y; Chen SY; Ross KN; Balk SP
    Cancer Res; 2006 Aug; 66(15):7783-92. PubMed ID: 16885382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raptor-rictor axis in TGFbeta-induced protein synthesis.
    Das F; Ghosh-Choudhury N; Mahimainathan L; Venkatesan B; Feliers D; Riley DJ; Kasinath BS; Choudhury GG
    Cell Signal; 2008 Feb; 20(2):409-23. PubMed ID: 18068336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin suppresses azoxymethane-induced colorectal aberrant crypt foci by activating AMP-activated protein kinase.
    Hosono K; Endo H; Takahashi H; Sugiyama M; Uchiyama T; Suzuki K; Nozaki Y; Yoneda K; Fujita K; Yoneda M; Inamori M; Tomatsu A; Chihara T; Shimpo K; Nakagama H; Nakajima A
    Mol Carcinog; 2010 Jul; 49(7):662-71. PubMed ID: 20564343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of mTOR signaling pathway contributes to survival of cervical cancer cells.
    Ji J; Zheng PS
    Gynecol Oncol; 2010 Apr; 117(1):103-8. PubMed ID: 20102778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferential dependence of breast cancer cells versus normal cells on integrin-linked kinase for protein kinase B/Akt activation and cell survival.
    Troussard AA; McDonald PC; Wederell ED; Mawji NM; Filipenko NR; Gelmon KA; Kucab JE; Dunn SE; Emerman JT; Bally MB; Dedhar S
    Cancer Res; 2006 Jan; 66(1):393-403. PubMed ID: 16397254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High glucose regulates cyclin D1/E of human mesenchymal stem cells through TGF-beta1 expression via Ca2+/PKC/MAPKs and PI3K/Akt/mTOR signal pathways.
    Ryu JM; Lee MY; Yun SP; Han HJ
    J Cell Physiol; 2010 Jul; 224(1):59-70. PubMed ID: 20232305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ca2+/calmodulin-dependent protein kinase kinase-alpha regulates skeletal muscle glucose uptake independent of AMP-activated protein kinase and Akt activation.
    Witczak CA; Fujii N; Hirshman MF; Goodyear LJ
    Diabetes; 2007 May; 56(5):1403-9. PubMed ID: 17287469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anthocyanins are novel AMPKα1 stimulators that suppress tumor growth by inhibiting mTOR phosphorylation.
    Lee YK; Lee WS; Kim GS; Park OJ
    Oncol Rep; 2010 Dec; 24(6):1471-7. PubMed ID: 21042741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lycopene inhibits growth of human colon cancer cells via suppression of the Akt signaling pathway.
    Tang FY; Shih CJ; Cheng LH; Ho HJ; Chen HJ
    Mol Nutr Food Res; 2008 Jun; 52(6):646-54. PubMed ID: 18537129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catechin-induced activation of the LKB1/AMP-activated protein kinase pathway.
    Murase T; Misawa K; Haramizu S; Hase T
    Biochem Pharmacol; 2009 Jul; 78(1):78-84. PubMed ID: 19447226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leucine stimulates mammalian target of rapamycin signaling in C2C12 myoblasts in part through inhibition of adenosine monophosphate-activated protein kinase.
    Du M; Shen QW; Zhu MJ; Ford SP
    J Anim Sci; 2007 Apr; 85(4):919-27. PubMed ID: 17178807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of AMP-activated protein kinase (AMPK) mediates plumbagin-induced apoptosis and growth inhibition in cultured human colon cancer cells.
    Chen MB; Zhang Y; Wei MX; Shen W; Wu XY; Yao C; Lu PH
    Cell Signal; 2013 Oct; 25(10):1993-2002. PubMed ID: 23712032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of adiponectin and metformin on prostate and colon neoplasia involve activation of AMP-activated protein kinase.
    Zakikhani M; Dowling RJ; Sonenberg N; Pollak MN
    Cancer Prev Res (Phila); 2008 Oct; 1(5):369-75. PubMed ID: 19138981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-Formyl-3,4-methylenedioxy-benzylidene-gamma-butyrolaetam, KNK437 induces caspase-3 activation through inhibition of mTORC1 activity in Cos-1 cells.
    Inoue H; Uyama T; Hayashi J; Watanabe A; Kobayashi K; Tadokoro T; Yamamoto Y
    Biochem Biophys Res Commun; 2010 Apr; 395(1):56-60. PubMed ID: 20350529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.